Amgen's Trading Volume Plummets 75.6% Ranking 102nd in Market

On March 24, 2025, Amgen's trading volume was $768 million, a 75.6% decrease from the previous day, ranking 102nd in the day's stock market. Amgen's stock price fell by 0.53%.

Legacy Investment Solutions LLC acquired a new stake in Amgen during the third quarter, valued at approximately $29,000. Synergy Investment Management LLC also purchased a new stake in the company.

Amgen is recognized as one of the top healthcare dividend stocks, known for its stable dividends and consistent performance. The company's dividends are a significant draw for investors seeking reliable income streams.

Amgen is among the pharmaceutical stocks to watch, alongside other major players like Pfizer, Merck & Co., Inc., Eli Lilly and Company, and AbbVie. The company's strong position in the healthcare sector makes it a key player to monitor.

Amgen's stock is also notable for its inclusion in various dividend-focused ETFs, such as Schwab Dividend Equity (SCHD) and ProShares S&P 500 Aristocrats (NOBL), which have shown positive performance this year. This inclusion highlights Amgen's status as a reliable dividend payer.